HIGHLIGHTS
- who: Deborah Theiler and collaborators from the Division of Nuclear Medicine, University Hospital of Basel, Basel, Switzerland have published the research work: Safety and Efficacy of Peptide-Receptor Radionuclide Therapy in Elderly Neuroendocrine Tumor Patients, in the Journal: (JOURNAL)
- what: All statistical analyses were performed on the full analysis set, although the main goal was to show non-inferiority with regard to safety and OS. The main results of this study can be summarised as follows: Despite a reduced haematological functional reserve, a lower eGFR and more comorbidities with a trend for a reduced WHO . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.